| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 20142181
[patent_doc_number] => RE050515
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2025-08-05
[patent_title] => Methods for producing ethylene and propylene from naphtha
[patent_app_type] => reissue
[patent_app_number] => 17/591192
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1847
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591192 | Methods for producing ethylene and propylene from naphtha | Feb 1, 2022 | Issued |
Array
(
[id] => 19372327
[patent_doc_number] => RE050082
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-08-20
[patent_title] => (5,6-dihydro)pyrimido[4,5-e]indolizines
[patent_app_type] => reissue
[patent_app_number] => 17/579990
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26606
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579990 | (5,6-dihydro)pyrimido[4,5-e]indolizines | Jan 19, 2022 | Issued |
| 17/554372 | ELIMINATION OF ORGANOHALO AND OXIRANE SPECIES IN CARBOXYLIC ACID ESTER STREAMS | Dec 16, 2021 | Abandoned |
Array
(
[id] => 19074673
[patent_doc_number] => RE049896
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-04-02
[patent_title] => Dehydrofluorination of 245FA to 1234ZE
[patent_app_type] => reissue
[patent_app_number] => 17/546174
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4384
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546174
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546174 | Dehydrofluorination of 245FA to 1234ZE | Dec 8, 2021 | Issued |
Array
(
[id] => 19272643
[patent_doc_number] => RE050030
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-07-02
[patent_title] => Methods to treat lymphoplasmacytic lymphoma
[patent_app_type] => reissue
[patent_app_number] => 17/534896
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 49944
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 796
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534896 | Methods to treat lymphoplasmacytic lymphoma | Nov 23, 2021 | Issued |
| 17/534995 | METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA | Nov 23, 2021 | Abandoned |
Array
(
[id] => 18962193
[patent_doc_number] => RE049834
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-02-13
[patent_title] => Jak1 selective inhibitors and uses thereof
[patent_app_type] => reissue
[patent_app_number] => 17/526799
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17456
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/526799 | Jak1 selective inhibitors and uses thereof | Nov 14, 2021 | Issued |
| 96/000377 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS IN AT RISK PATIENT POPULATIONS | Sep 28, 2021 | Pending |
| 96/000376 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS IN AT RISK PATIENT POPULATIONS | Sep 28, 2021 | Pending |
| 96/000374 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS IN AT RISK PATIENT POPULATIONS | Sep 28, 2021 | Pending |
| 96/000375 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS IN AT RISK PATIENT POPULATIONS | Sep 28, 2021 | Pending |
| 17/475109 | COMPOUNDS COMPRISING SELF-IMMOLATIVE GROUP | Sep 13, 2021 | Abandoned |
| 90/014855 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | Sep 9, 2021 | Issued |
Array
(
[id] => 20490930
[patent_doc_number] => RE050759
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2026-01-27
[patent_title] => Dental composite material having stable pasty property
[patent_app_type] => reissue
[patent_app_number] => 17/405590
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8824
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405590 | Dental composite material having stable pasty property | Aug 17, 2021 | Issued |
Array
(
[id] => 19194717
[patent_doc_number] => RE049985
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-05-28
[patent_title] => Electrostatic printing of cyclodextrin compositions
[patent_app_type] => reissue
[patent_app_number] => 17/400758
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18733
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400758 | Electrostatic printing of cyclodextrin compositions | Aug 11, 2021 | Issued |
| 17/386022 | PHOSPHORUS CONTAINING HETEROCYCLIC COMPOUNDS, SUGAR ANALOGUES, AND COMPOSITIONS HAVING ANTI-CANCER ACTIVITY CONTAINING THE SAME | Jul 26, 2021 | Abandoned |
| 17/378247 | NON-AQUEOUS SECONDARY BATTERY | Jul 15, 2021 | Abandoned |
Array
(
[id] => 18443046
[patent_doc_number] => RE049556
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-06-20
[patent_title] => Compounds and compositions as protein kinase inhibitors
[patent_app_type] => reissue
[patent_app_number] => 17/376199
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21344
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376199 | Compounds and compositions as protein kinase inhibitors | Jul 14, 2021 | Issued |
Array
(
[id] => 18993915
[patent_doc_number] => RE049851
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-02-27
[patent_title] => Pyridinylaminopyrimidine derivatives, preparation process and use thereof
[patent_app_type] => reissue
[patent_app_number] => 17/376987
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 13684
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376987 | Pyridinylaminopyrimidine derivatives, preparation process and use thereof | Jul 14, 2021 | Issued |
Array
(
[id] => 18946502
[patent_doc_number] => RE049826
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2024-02-06
[patent_title] => Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient
[patent_app_type] => reissue
[patent_app_number] => 17/367066
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9426
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367066 | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient | Jul 1, 2021 | Issued |